Although CD30-CAR T is mainly studied in cHL, several patients with ALCL were enrolled in different trials, with good tolerance, minimal fratricide, and some patients enjoyed durable CR (147, 151, 152). Here, TNFRSF8 is linked to classic Hodgkin lymphoma.